Galera Therapeutics - News Releases

Aug 10, 2020	Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates	View HTML PDF Version
Jul 30, 2020	Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference	View HTML PDF Version
Jul 13, 2020	Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer	View HTML PDF Version
May 29, 2020	Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin	View HTML PDF Version
May 18, 2020	Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease	View HTML PDF Version
May 13, 2020	Galera Therapeutics Announces New Data from the Phase 2b Trial on the Effect of Avasopasem Manganese on Cisplatin-Induced Chronic Kidney Disease to be Presented at ASCO 2020 Virtual Scientific Program	View HTML PDF Version
May 12, 2020	Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates	View HTML PDF Version
May 05, 2020	Galera Therapeutics to Present at BofA Securities 2020 Health Care Conference	View HTML PDF Version
Apr 30, 2020	Galera Therapeutics Announces Presentation of Avasopasem Manganese Data at ASCO 2020 Virtual Scientific Program	View HTML PDF Version
Apr 02, 2020	Galera Therapeutics Appoints Linda B. West to Board of Directors	View HTML PDF Version